BRAWNPharmaceuticals
Brawn Biotech Ltd — PE Ratio & Valuation Analysis
₹20.85
-0.71%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
✅
100.0% Discount to Industry
BRAWN P/E N/Ax vs sector avg 31.77x
💡
Understanding Brawn Biotech Ltd Valuation
Brawn Biotech Ltd (BRAWN) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-41.33%
Dividend Yield
0.00%
More on Brawn Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.